Atlas Venture

Offices: Cambridge (United States)

Stages: Seed, Series A, Series B

Markets: Life Sciences, BioTech, Therapeutics, Drug Discovery (Anti-Infective, Cardiovascular/Metabolic, Cell Therapy, CNS, Fibrosis, Gene Editing/Therapy, Hematology, Inflammation/Autoimmunity, Novel Modality, Oncology, Ophthalmology, Rare/Orphan Disease, Respiratory)